GRCL Stock Recent News

Does Gracell Biotechnologies Inc. Sponsored ADR (GRCL) have what it takes to be a top stock pick for momentum investors? Let's find out.

The Russell is up an astounding +26% from late October, largely thanks to signaled interest rate cuts from the Fed in 2024.

Gracell Biotechnologies Inc. Sponsored ADR (GRCL) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Does Gracell Biotechnologies Inc. Sponsored ADR (GRCL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Gracell Biotechnologies Inc. (NASDAQ:GRCL ) Q3 2023 Earnings Conference Call November 13, 2023 8:00 AM ET Company Participants William Cao - Chairman and CEO Wendy Li - Chief Medical Officer Kevin Xie - CFO Conference Call Participants Yigal Nochomovitz - Citi Benjamin Burnett - Stifel Dev Prasad - Jefferies Eric Schmidt - Cantor Emily Bodnar - H.C. Wainwright Yanan Zhu - Wells Fargo Securities Joseph Catanzaro - Piper Sandler Justin Zelin - BTIG Operator Ladies and gentlemen, thank you for standing by.

Gracell Biotechnologies (GRCL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Let us look at a few biotech companies, ACLX, LEGN, GRCL and EYEN, which are poised to beat third-quarter earnings estimates.

Oral presentation of the updated results from ongoing Phase 1 investigator-initiated study of GC012F in frontline setting for transplant-eligible, high-risk newly diagnosed multiple myeloma

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment of cancer and autoimmune disease, today announced that the management team will participate in four upcoming investor conferences in November. Stifel 2023 Healthcare Conference Fireside Chat: Tuesday, November 14th at 1:15 pm ETOne-on-one meetings: November 14th, 2023Presenter: Dr. Kevin Xie, Chief Financial OfficerLocation: New York Jefferies London Healthcare Conference Fireside Chat: Wednesday, November 15th at 11:30 am GMT / 6:30 am ETOne-on-one meetings: November 15th and 16th, 2023Presenter: Dr. Kevin Xie, Chief Financial OfficerLocation: London Piper Sandler 35 th Annual Healthcare Conference Presentation: Tuesday, November 28th at 12:00 pmOne-on-one meetings: November 28th, 2023Pres

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment of cancer and autoimmune diseases, today announced that it plans to release unaudited financial results for the third quarter ended September 30, 2023 and provide an update on recent developments prior to the open of the U.S. financial markets on Monday, November 13, 2023. The management team will host a live audio webcast and conference call at 8:00 AM Eastern Time.